Amid the measles outbreak, which is expected to “expand rapidly,” an expert explains how to stay protected from the virus ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.

Treatment-experienced patients with moderate to severe atopic dermatitis attained higher efficacy rates on rocatinlimab ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops encephalitis.

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...